Search results
Order by most recent / most popular / relevance
Results: 1-7 of 7
Third Circuit rules in favour of FTC view on pharmaceutical patent settlements
- Hogan Lovells
- -
- USA
- -
- August 9 2012
The US Court of Appeals for the Third Circuit recently issued a decision holding that pharmaceutical patent settlements that restrict generic entry and contain a payment to the generic company are presumptively unlawful under the antitrust laws
Third Circuit rules in favor of FTC view on pharmaceutical patent settlements: next stop, Supreme Court?
- Hogan Lovells
- -
- USA
- -
- July 19 2012
On 16 July 2012, the U.S. Court of Appeals for the Third Circuit issued a decision holding that pharmaceutical patent settlements that restrict generic entry and contain a payment to the generic company are presumptively unlawful under the antitrust laws
Eleventh Circuit deals FTC another setback in Androgel “reverse payment” case
- Hogan Lovells
- -
- USA
- -
- June 12 2012
On 25 April, the United States Court of Appeals for the Eleventh Circuit unanimously affirmed a district court’s dismissal of the FTC’s antitrust challenge to a so-called "reverse payment" patent settlement involving Solvay Pharmaceutical’s drug Androgel
Reverse payment patent settlements: split between FTC and courts continues
- Hogan Lovells
- -
- USA
- -
- March 31 2011
The Federal Trade Commission (FTC) is continuing its longstanding effort to stop patent settlements with so-called 'reverse payments', but the courts continue to analyse these settlements more leniently than the FTC
Update on "reverse payment" patent settlements: split between FTC and courts continues as Second Circuit declines to reverse course
- Hogan Lovells
- -
- USA
- -
- December 2 2010
The FTC is continuing its longstanding effort to stop patent settlements with so-called "reverse payments," but the courts continue to analyze these settlements more leniently than the FTC
Second Circuit panel urges reconsideration of precedent on antitrust treatment of patent settlements
- Hogan Lovells
- -
- USA
- -
- July 16 2010
A panel for the United States Court of Appeals for the Second Circuit, in an unusual move, urged plaintiffs in an antitrust case challenging a so-called "reverse payment" patent settlement to file an en banc petition to the Second Circuit to reconsider its existing precedent concerning such settlements
Courts split on whether to dismiss sham litigation antitrust claims
- Hogan Lovells
- -
- USA
- -
- July 16 2010
Two federal district courts have recently ruled on the sufficiency of claims brought by parties alleging that brand name drug manufacturers brought "sham" patent infringement litigation against them in violation of antitrust laws, in order to forestall generic entry
Current Search
- Jurisdiction - USA
- Workarea - Competition
- Workarea - Patents
- Workarea - Litigation
- Firm Name - Hogan Lovells